REQUEST A DEMO
Total
USD $0.00
Search more companies

Lyrus Life Sciences Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Lyrus Life Sciences Private Limited Profile Updated: May 20, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Lyrus Life Sciences Private Limited Is A Private Company Incorporated On 16 Jun 2015. The Company Is Classified As Non-Govt Company And Is Registered At Bangalore.

Legal Address
No.22, 7Th Cross, Jaibharath Nagar
Bangalore; Karnataka; Postal Code: 560033

Contact Details: Purchase the Lyrus Life Sciences Private Limited report to view the information.

Basic Information
Total Employees:
Purchase the Lyrus Life Sciences Private Limited report to view the information.
Outstanding Shares:
Purchase the Lyrus Life Sciences Private Limited report to view the information.
Registered Capital:
Purchase the Lyrus Life Sciences Private Limited report to view the information.
Incorporation Date:
June 16, 2015
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Company Secretary
Company Performance
Financial values in the chart are available after Lyrus Life Sciences Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
-23.48%
Total operating revenue
-19.81%
Operating profit (EBIT)
-872.91%
EBITDA
N/A
Net Profit (Loss) for the Period
-872.91%
Total assets
11.58%
Total equity
-81.72%
Operating Profit Margin (ROS)
-23.37%
Net Profit Margin
-23.37%
Return on Equity (ROE)
-454.52%
Debt to Equity Ratio
3797.68%
Quick Ratio
-0.01%
Cash Ratio
-0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?